A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon
Clinical trial NCT00498615 · COMPLETED
Trial details
- NCT number
- NCT00498615
- Sponsor
- Johns Hopkins University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2012-03-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.